A study led by anesthesiologists Miriam Treggiari, MD, PhD, and Ruba Sajdeya, MD, PhD, questions a widely accepted treatment strategy and could reshape ICU protocols.

Research led by Mikhail Nikiforov, PhD, professor of pathology, shows that blocking an enzyme involved in iron regulation kills multiple myeloma cancer cells and increases the effectiveness of current therapies.

Stories of resilience, innovation, and advocacy took center stage at Duke during the third annual ¡DALHE! Hispanic Heritage Month Celebration held on September 22.

Thanks to decades of work, Anna Mae Diehl, MD, is offering therapeutic promise for millions living with liver injury.

Duke Health emergency medicine physicians turn opioid overdose response into path to recovery.

A study in Nature Cell Biology has uncovered a surprising role for what was once considered “junk DNA,” showing that it helps stem cells sense their surroundings and decide what kind of cells to become during early development.

The project aims to bring early mental health screening to clinics where access to care is limited.

Each year, two million children and teens get a concussion. Pete Duquette, PhD, who leads Duke’s Pediatric Neuropsychology Clinic, offers tips to parents grounded in modern concussion care.

Duke diabetes and obesity researchers show alpha cells in the pancreas unexpectedly churn out potent, insulin-boosting GLP-1 to help control blood sugar.

In a study published in Nature, Duke researchers led by Trudy Oliver, PhD, reshape understanding of how small cell lung cancer begins, opening the door to developing therapies that could prevent this aggressive disease.